nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—panic disorder—Bupropion—obesity	0.24	1	CpDpCtD
Fluoxetine—Isoxsuprine—Phenylpropanolamine—obesity	0.0862	0.453	CrCrCtD
Fluoxetine—HTR2C—obesity	0.0568	0.345	CbGaD
Fluoxetine—SLC6A4—obesity	0.0471	0.286	CbGaD
Fluoxetine—Monobenzone—Benzphetamine—obesity	0.0399	0.21	CrCrCtD
Fluoxetine—HTR2A—obesity	0.0362	0.219	CbGaD
Fluoxetine—ALB—obesity	0.0247	0.15	CbGaD
Fluoxetine—Atomoxetine—Benzphetamine—obesity	0.024	0.126	CrCrCtD
Fluoxetine—SLC6A2—Diethylpropion—obesity	0.0237	0.0872	CbGbCtD
Fluoxetine—Bromodiphenhydramine—Benzphetamine—obesity	0.0224	0.118	CrCrCtD
Fluoxetine—SLC6A4—Sibutramine—obesity	0.0214	0.079	CbGbCtD
Fluoxetine—SLC6A2—Sibutramine—obesity	0.0179	0.0661	CbGbCtD
Fluoxetine—SLC6A2—Phendimetrazine—obesity	0.0179	0.0661	CbGbCtD
Fluoxetine—Orphenadrine—Benzphetamine—obesity	0.0176	0.0927	CrCrCtD
Fluoxetine—ORM1—Bupropion—obesity	0.0167	0.0615	CbGbCtD
Fluoxetine—SLC6A4—Phentermine—obesity	0.0163	0.0598	CbGbCtD
Fluoxetine—SLC6A2—Phentermine—obesity	0.0136	0.0501	CbGbCtD
Fluoxetine—SLC6A2—Benzphetamine—obesity	0.0136	0.0501	CbGbCtD
Fluoxetine—SLC6A4—Methamphetamine—obesity	0.013	0.0478	CbGbCtD
Fluoxetine—SLC6A2—Phenylpropanolamine—obesity	0.013	0.0478	CbGbCtD
Fluoxetine—SLC6A2—Bupropion—obesity	0.0116	0.0426	CbGbCtD
Fluoxetine—SLC6A2—Methamphetamine—obesity	0.0109	0.04	CbGbCtD
Fluoxetine—CYP2B6—Benzphetamine—obesity	0.00844	0.0311	CbGbCtD
Fluoxetine—CYP2B6—Bupropion—obesity	0.00718	0.0264	CbGbCtD
Fluoxetine—CYP1A2—Phentermine—obesity	0.00495	0.0182	CbGbCtD
Fluoxetine—CYP1A2—Phenylpropanolamine—obesity	0.00472	0.0174	CbGbCtD
Fluoxetine—CYP2C9—Phentermine—obesity	0.00446	0.0164	CbGbCtD
Fluoxetine—CYP1A2—Bupropion—obesity	0.00421	0.0155	CbGbCtD
Fluoxetine—CYP3A5—Cimetidine—obesity	0.00415	0.0153	CbGbCtD
Fluoxetine—CYP2D6—Phentermine—obesity	0.00408	0.015	CbGbCtD
Fluoxetine—CYP2C9—Bupropion—obesity	0.00379	0.014	CbGbCtD
Fluoxetine—CYP2D6—Bupropion—obesity	0.00347	0.0128	CbGbCtD
Fluoxetine—CYP3A4—Sibutramine—obesity	0.00342	0.0126	CbGbCtD
Fluoxetine—CYP2C19—Cimetidine—obesity	0.00335	0.0123	CbGbCtD
Fluoxetine—CYP2D6—Methamphetamine—obesity	0.00326	0.012	CbGbCtD
Fluoxetine—CYP1A2—Cimetidine—obesity	0.00309	0.0114	CbGbCtD
Fluoxetine—CYP2C9—Cimetidine—obesity	0.00278	0.0102	CbGbCtD
Fluoxetine—ABCB1—Cimetidine—obesity	0.0027	0.00994	CbGbCtD
Fluoxetine—CYP3A4—Benzphetamine—obesity	0.00259	0.00954	CbGbCtD
Fluoxetine—CYP2D6—Cimetidine—obesity	0.00254	0.00937	CbGbCtD
Fluoxetine—CYP3A4—Bupropion—obesity	0.0022	0.00811	CbGbCtD
Fluoxetine—CYP2C19—Topiramate—obesity	0.00219	0.00806	CbGbCtD
Fluoxetine—ORM1—bile—obesity	0.00187	0.117	CbGeAlD
Fluoxetine—CYP3A4—Orlistat—obesity	0.0018	0.00661	CbGbCtD
Fluoxetine—CYP3A4—Cimetidine—obesity	0.00162	0.00596	CbGbCtD
Fluoxetine—SLC6A2—sympathetic nervous system—obesity	0.0014	0.0875	CbGeAlD
Fluoxetine—CYP3A4—Topiramate—obesity	0.00106	0.0039	CbGbCtD
Fluoxetine—SLC6A2—autonomic nervous system—obesity	0.000939	0.0588	CbGeAlD
Fluoxetine—HTR2A—sympathetic nervous system—obesity	0.000839	0.0526	CbGeAlD
Fluoxetine—HTR2A—vagus nerve—obesity	0.000813	0.0509	CbGeAlD
Fluoxetine—Duloxetine—NPY1R—obesity	0.000604	0.424	CrCbGaD
Fluoxetine—HTR2A—autonomic nervous system—obesity	0.000564	0.0354	CbGeAlD
Fluoxetine—ORM1—gall bladder—obesity	0.00052	0.0326	CbGeAlD
Fluoxetine—ALB—gall bladder—obesity	0.000456	0.0286	CbGeAlD
Fluoxetine—SLC6A4—hindbrain—obesity	0.000449	0.0282	CbGeAlD
Fluoxetine—Atomoxetine—NPY1R—obesity	0.000316	0.222	CrCbGaD
Fluoxetine—SIGMAR1—islet of Langerhans—obesity	0.000288	0.0181	CbGeAlD
Fluoxetine—SLC6A4—respiratory system—obesity	0.000274	0.0172	CbGeAlD
Fluoxetine—SLC6A2—respiratory system—obesity	0.000241	0.0151	CbGeAlD
Fluoxetine—HTR2A—hindbrain—obesity	0.000238	0.0149	CbGeAlD
Fluoxetine—SIGMAR1—adrenal cortex—obesity	0.000229	0.0143	CbGeAlD
Fluoxetine—CYP2D6—hindbrain—obesity	0.000216	0.0136	CbGeAlD
Fluoxetine—CYP3A5—islet of Langerhans—obesity	0.00019	0.0119	CbGeAlD
Fluoxetine—CYP1A2—respiratory system—obesity	0.000186	0.0116	CbGeAlD
Fluoxetine—SIGMAR1—pituitary gland—obesity	0.000185	0.0116	CbGeAlD
Fluoxetine—SIGMAR1—adipose tissue—obesity	0.000184	0.0115	CbGeAlD
Fluoxetine—CYP3A5—respiratory system—obesity	0.000179	0.0112	CbGeAlD
Fluoxetine—CYP2B6—respiratory system—obesity	0.000178	0.0112	CbGeAlD
Fluoxetine—SLC6A4—digestive system—obesity	0.000174	0.0109	CbGeAlD
Fluoxetine—ALB—adrenal gland—obesity	0.000171	0.0107	CbGeAlD
Fluoxetine—ORM1—endocrine gland—obesity	0.000169	0.0106	CbGeAlD
Fluoxetine—SIGMAR1—adrenal gland—obesity	0.000165	0.0103	CbGeAlD
Fluoxetine—ORM1—liver—obesity	0.000152	0.00956	CbGeAlD
Fluoxetine—CYP2B6—adrenal cortex—obesity	0.000149	0.00936	CbGeAlD
Fluoxetine—SLC6A2—adrenal gland—obesity	0.000146	0.00917	CbGeAlD
Fluoxetine—HTR2A—respiratory system—obesity	0.000145	0.0091	CbGeAlD
Fluoxetine—CYP2C19—digestive system—obesity	0.000144	0.00906	CbGeAlD
Fluoxetine—SLC6A4—endocrine gland—obesity	0.000144	0.00903	CbGeAlD
Fluoxetine—CYP2B6—cardiovascular system—obesity	0.000136	0.00854	CbGeAlD
Fluoxetine—CYP2C9—cardiovascular system—obesity	0.000135	0.00846	CbGeAlD
Fluoxetine—ALB—liver—obesity	0.000134	0.00838	CbGeAlD
Fluoxetine—SIGMAR1—liver—obesity	0.000129	0.00809	CbGeAlD
Fluoxetine—SLC6A2—endocrine gland—obesity	0.000127	0.00795	CbGeAlD
Fluoxetine—CYP3A5—adipose tissue—obesity	0.000121	0.00758	CbGeAlD
Fluoxetine—CYP2C19—endocrine gland—obesity	0.000119	0.00748	CbGeAlD
Fluoxetine—CYP1A2—digestive system—obesity	0.000118	0.0074	CbGeAlD
Fluoxetine—CYP3A5—digestive system—obesity	0.000114	0.00714	CbGeAlD
Fluoxetine—CYP2B6—digestive system—obesity	0.000113	0.00709	CbGeAlD
Fluoxetine—CYP2C9—digestive system—obesity	0.000112	0.00702	CbGeAlD
Fluoxetine—HTR2A—cardiovascular system—obesity	0.000111	0.00697	CbGeAlD
Fluoxetine—CYP2B6—adrenal gland—obesity	0.000108	0.00676	CbGeAlD
Fluoxetine—CYP2C19—liver—obesity	0.000108	0.00675	CbGeAlD
Fluoxetine—Duloxetine—HTR2C—obesity	0.000107	0.075	CrCbGaD
Fluoxetine—ABCB1—islet of Langerhans—obesity	0.000101	0.00631	CbGeAlD
Fluoxetine—HTR2A—pituitary gland—obesity	9.84e-05	0.00617	CbGeAlD
Fluoxetine—CYP1A2—endocrine gland—obesity	9.75e-05	0.00611	CbGeAlD
Fluoxetine—ABCB1—respiratory system—obesity	9.51e-05	0.00596	CbGeAlD
Fluoxetine—CYP3A5—endocrine gland—obesity	9.41e-05	0.0059	CbGeAlD
Fluoxetine—CYP2B6—endocrine gland—obesity	9.35e-05	0.00586	CbGeAlD
Fluoxetine—CYP2C9—endocrine gland—obesity	9.26e-05	0.0058	CbGeAlD
Fluoxetine—HTR2A—digestive system—obesity	9.23e-05	0.00578	CbGeAlD
Fluoxetine—Duloxetine—SLC6A4—obesity	8.86e-05	0.0622	CrCbGaD
Fluoxetine—HTR2A—adrenal gland—obesity	8.79e-05	0.00551	CbGeAlD
Fluoxetine—CYP1A2—liver—obesity	8.79e-05	0.00551	CbGeAlD
Fluoxetine—CYP3A4—digestive system—obesity	8.54e-05	0.00535	CbGeAlD
Fluoxetine—CYP3A5—liver—obesity	8.48e-05	0.00532	CbGeAlD
Fluoxetine—CYP2B6—liver—obesity	8.43e-05	0.00528	CbGeAlD
Fluoxetine—CYP2D6—digestive system—obesity	8.41e-05	0.00527	CbGeAlD
Fluoxetine—CYP2C9—liver—obesity	8.35e-05	0.00523	CbGeAlD
Fluoxetine—ABCB1—adrenal cortex—obesity	7.98e-05	0.005	CbGeAlD
Fluoxetine—HTR2A—endocrine gland—obesity	7.62e-05	0.00478	CbGeAlD
Fluoxetine—ABCB1—cardiovascular system—obesity	7.28e-05	0.00457	CbGeAlD
Fluoxetine—CYP3A4—endocrine gland—obesity	7.06e-05	0.00442	CbGeAlD
Fluoxetine—CYP2D6—endocrine gland—obesity	6.95e-05	0.00435	CbGeAlD
Fluoxetine—HTR2A—liver—obesity	6.87e-05	0.00431	CbGeAlD
Fluoxetine—Atomoxetine—HTR1B—obesity	6.87e-05	0.0482	CrCbGaD
Fluoxetine—Duloxetine—HTR2A—obesity	6.81e-05	0.0478	CrCbGaD
Fluoxetine—ABCB1—pituitary gland—obesity	6.45e-05	0.00404	CbGeAlD
Fluoxetine—ABCB1—adipose tissue—obesity	6.42e-05	0.00403	CbGeAlD
Fluoxetine—CYP3A4—liver—obesity	6.36e-05	0.00399	CbGeAlD
Fluoxetine—CYP2D6—liver—obesity	6.26e-05	0.00393	CbGeAlD
Fluoxetine—ABCB1—digestive system—obesity	6.05e-05	0.00379	CbGeAlD
Fluoxetine—ABCB1—adrenal gland—obesity	5.76e-05	0.00361	CbGeAlD
Fluoxetine—Atomoxetine—HTR2C—obesity	5.6e-05	0.0393	CrCbGaD
Fluoxetine—ABCB1—endocrine gland—obesity	5e-05	0.00313	CbGeAlD
Fluoxetine—Atomoxetine—SLC6A4—obesity	4.64e-05	0.0326	CrCbGaD
Fluoxetine—ABCB1—liver—obesity	4.5e-05	0.00282	CbGeAlD
Fluoxetine—Atomoxetine—HTR2A—obesity	3.57e-05	0.025	CrCbGaD
Fluoxetine—Orphenadrine—CYP2E1—obesity	3.39e-05	0.0238	CrCbGaD
Fluoxetine—Discomfort—Orlistat—obesity	2.96e-05	0.000368	CcSEcCtD
Fluoxetine—Ataxia—Topiramate—obesity	2.96e-05	0.000367	CcSEcCtD
Fluoxetine—Convulsion—Sibutramine—obesity	2.96e-05	0.000366	CcSEcCtD
Fluoxetine—Hypertension—Sibutramine—obesity	2.94e-05	0.000365	CcSEcCtD
Fluoxetine—Dry mouth—Orlistat—obesity	2.93e-05	0.000364	CcSEcCtD
Fluoxetine—Flatulence—Bupropion—obesity	2.93e-05	0.000363	CcSEcCtD
Fluoxetine—Dehydration—Topiramate—obesity	2.93e-05	0.000363	CcSEcCtD
Fluoxetine—Tension—Bupropion—obesity	2.92e-05	0.000362	CcSEcCtD
Fluoxetine—Dysgeusia—Bupropion—obesity	2.91e-05	0.000361	CcSEcCtD
Fluoxetine—Liver function test abnormal—Topiramate—obesity	2.9e-05	0.00036	CcSEcCtD
Fluoxetine—Myalgia—Sibutramine—obesity	2.9e-05	0.00036	CcSEcCtD
Fluoxetine—Chest pain—Sibutramine—obesity	2.9e-05	0.00036	CcSEcCtD
Fluoxetine—Arthralgia—Sibutramine—obesity	2.9e-05	0.00036	CcSEcCtD
Fluoxetine—Anxiety—Sibutramine—obesity	2.89e-05	0.000359	CcSEcCtD
Fluoxetine—Nervousness—Bupropion—obesity	2.89e-05	0.000358	CcSEcCtD
Fluoxetine—Anaphylactic shock—Orlistat—obesity	2.88e-05	0.000357	CcSEcCtD
Fluoxetine—Back pain—Bupropion—obesity	2.88e-05	0.000357	CcSEcCtD
Fluoxetine—Orthostatic hypotension—Topiramate—obesity	2.87e-05	0.000356	CcSEcCtD
Fluoxetine—Discomfort—Sibutramine—obesity	2.87e-05	0.000356	CcSEcCtD
Fluoxetine—Hypokalaemia—Topiramate—obesity	2.86e-05	0.000355	CcSEcCtD
Fluoxetine—Muscle spasms—Bupropion—obesity	2.86e-05	0.000354	CcSEcCtD
Fluoxetine—Infection—Orlistat—obesity	2.86e-05	0.000354	CcSEcCtD
Fluoxetine—Breast disorder—Topiramate—obesity	2.84e-05	0.000352	CcSEcCtD
Fluoxetine—Dry mouth—Sibutramine—obesity	2.84e-05	0.000352	CcSEcCtD
Fluoxetine—Toxic epidermal necrolysis—Topiramate—obesity	2.83e-05	0.000351	CcSEcCtD
Fluoxetine—Confusional state—Sibutramine—obesity	2.81e-05	0.000348	CcSEcCtD
Fluoxetine—Skin disorder—Orlistat—obesity	2.79e-05	0.000346	CcSEcCtD
Fluoxetine—Tremor—Bupropion—obesity	2.79e-05	0.000345	CcSEcCtD
Fluoxetine—Gastritis—Topiramate—obesity	2.78e-05	0.000345	CcSEcCtD
Fluoxetine—Anaphylactic shock—Sibutramine—obesity	2.78e-05	0.000345	CcSEcCtD
Fluoxetine—Hyperhidrosis—Orlistat—obesity	2.78e-05	0.000345	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Topiramate—obesity	2.77e-05	0.000344	CcSEcCtD
Fluoxetine—Muscular weakness—Topiramate—obesity	2.77e-05	0.000344	CcSEcCtD
Fluoxetine—Infection—Sibutramine—obesity	2.77e-05	0.000343	CcSEcCtD
Fluoxetine—Ill-defined disorder—Bupropion—obesity	2.76e-05	0.000342	CcSEcCtD
Fluoxetine—Anaemia—Bupropion—obesity	2.75e-05	0.000341	CcSEcCtD
Fluoxetine—Shock—Sibutramine—obesity	2.74e-05	0.00034	CcSEcCtD
Fluoxetine—Abdominal distension—Topiramate—obesity	2.74e-05	0.000339	CcSEcCtD
Fluoxetine—Agitation—Bupropion—obesity	2.73e-05	0.000339	CcSEcCtD
Fluoxetine—Thrombocytopenia—Sibutramine—obesity	2.73e-05	0.000338	CcSEcCtD
Fluoxetine—Dysphagia—Topiramate—obesity	2.72e-05	0.000337	CcSEcCtD
Fluoxetine—Asthma—Topiramate—obesity	2.72e-05	0.000337	CcSEcCtD
Fluoxetine—Angioedema—Bupropion—obesity	2.72e-05	0.000337	CcSEcCtD
Fluoxetine—Tachycardia—Sibutramine—obesity	2.72e-05	0.000337	CcSEcCtD
Fluoxetine—Skin disorder—Sibutramine—obesity	2.7e-05	0.000335	CcSEcCtD
Fluoxetine—Eosinophilia—Topiramate—obesity	2.69e-05	0.000334	CcSEcCtD
Fluoxetine—Hyperhidrosis—Sibutramine—obesity	2.69e-05	0.000334	CcSEcCtD
Fluoxetine—Malaise—Bupropion—obesity	2.68e-05	0.000332	CcSEcCtD
Fluoxetine—Vertigo—Bupropion—obesity	2.67e-05	0.000331	CcSEcCtD
Fluoxetine—Syncope—Bupropion—obesity	2.67e-05	0.000331	CcSEcCtD
Fluoxetine—Pancreatitis—Topiramate—obesity	2.67e-05	0.00033	CcSEcCtD
Fluoxetine—Leukopenia—Bupropion—obesity	2.66e-05	0.00033	CcSEcCtD
Fluoxetine—Anorexia—Sibutramine—obesity	2.65e-05	0.000329	CcSEcCtD
Fluoxetine—Sweating increased—Topiramate—obesity	2.65e-05	0.000328	CcSEcCtD
Fluoxetine—Angina pectoris—Topiramate—obesity	2.65e-05	0.000328	CcSEcCtD
Fluoxetine—Palpitations—Bupropion—obesity	2.63e-05	0.000326	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Orlistat—obesity	2.62e-05	0.000325	CcSEcCtD
Fluoxetine—Bronchitis—Topiramate—obesity	2.61e-05	0.000324	CcSEcCtD
Fluoxetine—Loss of consciousness—Bupropion—obesity	2.61e-05	0.000324	CcSEcCtD
Fluoxetine—Insomnia—Orlistat—obesity	2.6e-05	0.000323	CcSEcCtD
Fluoxetine—Hypotension—Sibutramine—obesity	2.6e-05	0.000322	CcSEcCtD
Fluoxetine—Cough—Bupropion—obesity	2.59e-05	0.000322	CcSEcCtD
Fluoxetine—Paraesthesia—Orlistat—obesity	2.58e-05	0.00032	CcSEcCtD
Fluoxetine—Pancytopenia—Topiramate—obesity	2.58e-05	0.00032	CcSEcCtD
Fluoxetine—Convulsion—Bupropion—obesity	2.58e-05	0.000319	CcSEcCtD
Fluoxetine—Hypertension—Bupropion—obesity	2.57e-05	0.000318	CcSEcCtD
Fluoxetine—Dysuria—Topiramate—obesity	2.54e-05	0.000315	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Sibutramine—obesity	2.54e-05	0.000314	CcSEcCtD
Fluoxetine—Dyspepsia—Orlistat—obesity	2.53e-05	0.000314	CcSEcCtD
Fluoxetine—Arthralgia—Bupropion—obesity	2.53e-05	0.000314	CcSEcCtD
Fluoxetine—Myalgia—Bupropion—obesity	2.53e-05	0.000314	CcSEcCtD
Fluoxetine—Chest pain—Bupropion—obesity	2.53e-05	0.000314	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Topiramate—obesity	2.53e-05	0.000313	CcSEcCtD
Fluoxetine—Anxiety—Bupropion—obesity	2.52e-05	0.000313	CcSEcCtD
Fluoxetine—Insomnia—Sibutramine—obesity	2.52e-05	0.000312	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	2.51e-05	0.000312	CcSEcCtD
Fluoxetine—Pollakiuria—Topiramate—obesity	2.51e-05	0.000311	CcSEcCtD
Fluoxetine—Erectile dysfunction—Topiramate—obesity	2.5e-05	0.00031	CcSEcCtD
Fluoxetine—Discomfort—Bupropion—obesity	2.5e-05	0.00031	CcSEcCtD
Fluoxetine—Decreased appetite—Orlistat—obesity	2.5e-05	0.00031	CcSEcCtD
Fluoxetine—Paraesthesia—Sibutramine—obesity	2.5e-05	0.00031	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Orlistat—obesity	2.48e-05	0.000308	CcSEcCtD
Fluoxetine—Dyspnoea—Sibutramine—obesity	2.48e-05	0.000308	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Topiramate—obesity	2.48e-05	0.000308	CcSEcCtD
Fluoxetine—Fatigue—Orlistat—obesity	2.48e-05	0.000307	CcSEcCtD
Fluoxetine—Dry mouth—Bupropion—obesity	2.48e-05	0.000307	CcSEcCtD
Fluoxetine—Somnolence—Sibutramine—obesity	2.47e-05	0.000307	CcSEcCtD
Fluoxetine—Weight increased—Topiramate—obesity	2.47e-05	0.000307	CcSEcCtD
Fluoxetine—Weight decreased—Topiramate—obesity	2.46e-05	0.000305	CcSEcCtD
Fluoxetine—Pain—Orlistat—obesity	2.46e-05	0.000305	CcSEcCtD
Fluoxetine—Hyperglycaemia—Topiramate—obesity	2.45e-05	0.000304	CcSEcCtD
Fluoxetine—Dyspepsia—Sibutramine—obesity	2.45e-05	0.000304	CcSEcCtD
Fluoxetine—Confusional state—Bupropion—obesity	2.45e-05	0.000303	CcSEcCtD
Fluoxetine—Pneumonia—Topiramate—obesity	2.44e-05	0.000302	CcSEcCtD
Fluoxetine—Anaphylactic shock—Bupropion—obesity	2.43e-05	0.000301	CcSEcCtD
Fluoxetine—Decreased appetite—Sibutramine—obesity	2.42e-05	0.0003	CcSEcCtD
Fluoxetine—Depression—Topiramate—obesity	2.42e-05	0.0003	CcSEcCtD
Fluoxetine—Infection—Bupropion—obesity	2.41e-05	0.000299	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Topiramate—obesity	2.4e-05	0.000298	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Sibutramine—obesity	2.4e-05	0.000298	CcSEcCtD
Fluoxetine—Shock—Bupropion—obesity	2.39e-05	0.000296	CcSEcCtD
Fluoxetine—Renal failure—Topiramate—obesity	2.38e-05	0.000295	CcSEcCtD
Fluoxetine—Pain—Sibutramine—obesity	2.38e-05	0.000295	CcSEcCtD
Fluoxetine—Constipation—Sibutramine—obesity	2.38e-05	0.000295	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Topiramate—obesity	2.38e-05	0.000295	CcSEcCtD
Fluoxetine—Thrombocytopenia—Bupropion—obesity	2.38e-05	0.000295	CcSEcCtD
Fluoxetine—Feeling abnormal—Orlistat—obesity	2.37e-05	0.000294	CcSEcCtD
Fluoxetine—Tachycardia—Bupropion—obesity	2.37e-05	0.000294	CcSEcCtD
Fluoxetine—Stomatitis—Topiramate—obesity	2.36e-05	0.000293	CcSEcCtD
Fluoxetine—Skin disorder—Bupropion—obesity	2.36e-05	0.000292	CcSEcCtD
Fluoxetine—Conjunctivitis—Topiramate—obesity	2.36e-05	0.000292	CcSEcCtD
Fluoxetine—Urinary tract infection—Topiramate—obesity	2.36e-05	0.000292	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Orlistat—obesity	2.35e-05	0.000292	CcSEcCtD
Fluoxetine—Hyperhidrosis—Bupropion—obesity	2.35e-05	0.000291	CcSEcCtD
Fluoxetine—Anorexia—Bupropion—obesity	2.31e-05	0.000287	CcSEcCtD
Fluoxetine—Haematuria—Topiramate—obesity	2.31e-05	0.000287	CcSEcCtD
Fluoxetine—Feeling abnormal—Sibutramine—obesity	2.29e-05	0.000284	CcSEcCtD
Fluoxetine—Epistaxis—Topiramate—obesity	2.29e-05	0.000283	CcSEcCtD
Fluoxetine—Urticaria—Orlistat—obesity	2.28e-05	0.000283	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Sibutramine—obesity	2.28e-05	0.000282	CcSEcCtD
Fluoxetine—Sinusitis—Topiramate—obesity	2.27e-05	0.000282	CcSEcCtD
Fluoxetine—Abdominal pain—Orlistat—obesity	2.27e-05	0.000282	CcSEcCtD
Fluoxetine—Body temperature increased—Orlistat—obesity	2.27e-05	0.000282	CcSEcCtD
Fluoxetine—Hypotension—Bupropion—obesity	2.27e-05	0.000281	CcSEcCtD
Fluoxetine—Bradycardia—Topiramate—obesity	2.22e-05	0.000275	CcSEcCtD
Fluoxetine—Urticaria—Sibutramine—obesity	2.21e-05	0.000274	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Bupropion—obesity	2.21e-05	0.000274	CcSEcCtD
Fluoxetine—Abdominal pain—Sibutramine—obesity	2.2e-05	0.000273	CcSEcCtD
Fluoxetine—Body temperature increased—Sibutramine—obesity	2.2e-05	0.000273	CcSEcCtD
Fluoxetine—Insomnia—Bupropion—obesity	2.19e-05	0.000272	CcSEcCtD
Fluoxetine—Haemoglobin—Topiramate—obesity	2.19e-05	0.000271	CcSEcCtD
Fluoxetine—Rhinitis—Topiramate—obesity	2.18e-05	0.00027	CcSEcCtD
Fluoxetine—Paraesthesia—Bupropion—obesity	2.18e-05	0.00027	CcSEcCtD
Fluoxetine—Haemorrhage—Topiramate—obesity	2.18e-05	0.00027	CcSEcCtD
Fluoxetine—Hepatitis—Topiramate—obesity	2.18e-05	0.00027	CcSEcCtD
Fluoxetine—Hallucination—Topiramate—obesity	2.17e-05	0.000268	CcSEcCtD
Fluoxetine—Hypoaesthesia—Topiramate—obesity	2.17e-05	0.000268	CcSEcCtD
Fluoxetine—Dyspnoea—Bupropion—obesity	2.16e-05	0.000268	CcSEcCtD
Fluoxetine—Pharyngitis—Topiramate—obesity	2.16e-05	0.000268	CcSEcCtD
Fluoxetine—Somnolence—Bupropion—obesity	2.16e-05	0.000267	CcSEcCtD
Fluoxetine—Oedema peripheral—Topiramate—obesity	2.14e-05	0.000266	CcSEcCtD
Fluoxetine—Dyspepsia—Bupropion—obesity	2.14e-05	0.000265	CcSEcCtD
Fluoxetine—Hypersensitivity—Orlistat—obesity	2.12e-05	0.000263	CcSEcCtD
Fluoxetine—Decreased appetite—Bupropion—obesity	2.11e-05	0.000262	CcSEcCtD
Fluoxetine—Visual impairment—Topiramate—obesity	2.1e-05	0.00026	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Bupropion—obesity	2.1e-05	0.00026	CcSEcCtD
Fluoxetine—Fatigue—Bupropion—obesity	2.09e-05	0.000259	CcSEcCtD
Fluoxetine—Pain—Bupropion—obesity	2.08e-05	0.000257	CcSEcCtD
Fluoxetine—Constipation—Bupropion—obesity	2.08e-05	0.000257	CcSEcCtD
Fluoxetine—Asthenia—Orlistat—obesity	2.06e-05	0.000256	CcSEcCtD
Fluoxetine—Erythema multiforme—Topiramate—obesity	2.06e-05	0.000255	CcSEcCtD
Fluoxetine—Hypersensitivity—Sibutramine—obesity	2.05e-05	0.000254	CcSEcCtD
Fluoxetine—Pruritus—Orlistat—obesity	2.03e-05	0.000252	CcSEcCtD
Fluoxetine—Tinnitus—Topiramate—obesity	2.03e-05	0.000252	CcSEcCtD
Fluoxetine—Feeling abnormal—Bupropion—obesity	2e-05	0.000248	CcSEcCtD
Fluoxetine—Asthenia—Sibutramine—obesity	2e-05	0.000248	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Bupropion—obesity	1.98e-05	0.000246	CcSEcCtD
Fluoxetine—Pruritus—Sibutramine—obesity	1.97e-05	0.000244	CcSEcCtD
Fluoxetine—Diarrhoea—Orlistat—obesity	1.97e-05	0.000244	CcSEcCtD
Fluoxetine—Chills—Topiramate—obesity	1.95e-05	0.000242	CcSEcCtD
Fluoxetine—Urticaria—Bupropion—obesity	1.93e-05	0.000239	CcSEcCtD
Fluoxetine—Alopecia—Topiramate—obesity	1.92e-05	0.000238	CcSEcCtD
Fluoxetine—Abdominal pain—Bupropion—obesity	1.92e-05	0.000238	CcSEcCtD
Fluoxetine—Body temperature increased—Bupropion—obesity	1.92e-05	0.000238	CcSEcCtD
Fluoxetine—Mental disorder—Topiramate—obesity	1.91e-05	0.000236	CcSEcCtD
Fluoxetine—Diarrhoea—Sibutramine—obesity	1.9e-05	0.000236	CcSEcCtD
Fluoxetine—Dizziness—Orlistat—obesity	1.9e-05	0.000236	CcSEcCtD
Fluoxetine—Malnutrition—Topiramate—obesity	1.89e-05	0.000235	CcSEcCtD
Fluoxetine—Flatulence—Topiramate—obesity	1.87e-05	0.000231	CcSEcCtD
Fluoxetine—Tension—Topiramate—obesity	1.86e-05	0.00023	CcSEcCtD
Fluoxetine—Dysgeusia—Topiramate—obesity	1.86e-05	0.00023	CcSEcCtD
Fluoxetine—Dizziness—Sibutramine—obesity	1.84e-05	0.000228	CcSEcCtD
Fluoxetine—Nervousness—Topiramate—obesity	1.84e-05	0.000228	CcSEcCtD
Fluoxetine—Back pain—Topiramate—obesity	1.83e-05	0.000227	CcSEcCtD
Fluoxetine—Vomiting—Orlistat—obesity	1.83e-05	0.000227	CcSEcCtD
Fluoxetine—Muscle spasms—Topiramate—obesity	1.82e-05	0.000226	CcSEcCtD
Fluoxetine—Rash—Orlistat—obesity	1.81e-05	0.000225	CcSEcCtD
Fluoxetine—Dermatitis—Orlistat—obesity	1.81e-05	0.000225	CcSEcCtD
Fluoxetine—Headache—Orlistat—obesity	1.8e-05	0.000223	CcSEcCtD
Fluoxetine—Hypersensitivity—Bupropion—obesity	1.79e-05	0.000222	CcSEcCtD
Fluoxetine—Tremor—Topiramate—obesity	1.77e-05	0.00022	CcSEcCtD
Fluoxetine—Vomiting—Sibutramine—obesity	1.77e-05	0.000219	CcSEcCtD
Fluoxetine—Ill-defined disorder—Topiramate—obesity	1.76e-05	0.000218	CcSEcCtD
Fluoxetine—Rash—Sibutramine—obesity	1.76e-05	0.000218	CcSEcCtD
Fluoxetine—Dermatitis—Sibutramine—obesity	1.75e-05	0.000217	CcSEcCtD
Fluoxetine—Anaemia—Topiramate—obesity	1.75e-05	0.000217	CcSEcCtD
Fluoxetine—Headache—Sibutramine—obesity	1.74e-05	0.000216	CcSEcCtD
Fluoxetine—Asthenia—Bupropion—obesity	1.74e-05	0.000216	CcSEcCtD
Fluoxetine—Agitation—Topiramate—obesity	1.74e-05	0.000216	CcSEcCtD
Fluoxetine—Pruritus—Bupropion—obesity	1.72e-05	0.000213	CcSEcCtD
Fluoxetine—Nausea—Orlistat—obesity	1.71e-05	0.000212	CcSEcCtD
Fluoxetine—Malaise—Topiramate—obesity	1.71e-05	0.000212	CcSEcCtD
Fluoxetine—Vertigo—Topiramate—obesity	1.7e-05	0.000211	CcSEcCtD
Fluoxetine—Syncope—Topiramate—obesity	1.7e-05	0.000211	CcSEcCtD
Fluoxetine—Leukopenia—Topiramate—obesity	1.7e-05	0.00021	CcSEcCtD
Fluoxetine—Palpitations—Topiramate—obesity	1.67e-05	0.000208	CcSEcCtD
Fluoxetine—Loss of consciousness—Topiramate—obesity	1.66e-05	0.000206	CcSEcCtD
Fluoxetine—Diarrhoea—Bupropion—obesity	1.66e-05	0.000206	CcSEcCtD
Fluoxetine—Nausea—Sibutramine—obesity	1.65e-05	0.000205	CcSEcCtD
Fluoxetine—Cough—Topiramate—obesity	1.65e-05	0.000205	CcSEcCtD
Fluoxetine—Convulsion—Topiramate—obesity	1.64e-05	0.000203	CcSEcCtD
Fluoxetine—Hypertension—Topiramate—obesity	1.64e-05	0.000203	CcSEcCtD
Fluoxetine—Myalgia—Topiramate—obesity	1.61e-05	0.0002	CcSEcCtD
Fluoxetine—Arthralgia—Topiramate—obesity	1.61e-05	0.0002	CcSEcCtD
Fluoxetine—Chest pain—Topiramate—obesity	1.61e-05	0.0002	CcSEcCtD
Fluoxetine—Anxiety—Topiramate—obesity	1.61e-05	0.000199	CcSEcCtD
Fluoxetine—Dizziness—Bupropion—obesity	1.6e-05	0.000199	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	1.6e-05	0.000199	CcSEcCtD
Fluoxetine—Discomfort—Topiramate—obesity	1.59e-05	0.000198	CcSEcCtD
Fluoxetine—Dry mouth—Topiramate—obesity	1.58e-05	0.000196	CcSEcCtD
Fluoxetine—Confusional state—Topiramate—obesity	1.56e-05	0.000193	CcSEcCtD
Fluoxetine—Vomiting—Bupropion—obesity	1.54e-05	0.000191	CcSEcCtD
Fluoxetine—Infection—Topiramate—obesity	1.54e-05	0.00019	CcSEcCtD
Fluoxetine—Rash—Bupropion—obesity	1.53e-05	0.00019	CcSEcCtD
Fluoxetine—Dermatitis—Bupropion—obesity	1.53e-05	0.00019	CcSEcCtD
Fluoxetine—Shock—Topiramate—obesity	1.52e-05	0.000189	CcSEcCtD
Fluoxetine—Headache—Bupropion—obesity	1.52e-05	0.000188	CcSEcCtD
Fluoxetine—Thrombocytopenia—Topiramate—obesity	1.51e-05	0.000188	CcSEcCtD
Fluoxetine—Tachycardia—Topiramate—obesity	1.51e-05	0.000187	CcSEcCtD
Fluoxetine—Skin disorder—Topiramate—obesity	1.5e-05	0.000186	CcSEcCtD
Fluoxetine—Hyperhidrosis—Topiramate—obesity	1.49e-05	0.000185	CcSEcCtD
Fluoxetine—Anorexia—Topiramate—obesity	1.47e-05	0.000183	CcSEcCtD
Fluoxetine—Hypotension—Topiramate—obesity	1.44e-05	0.000179	CcSEcCtD
Fluoxetine—Nausea—Bupropion—obesity	1.44e-05	0.000179	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Topiramate—obesity	1.41e-05	0.000175	CcSEcCtD
Fluoxetine—Insomnia—Topiramate—obesity	1.4e-05	0.000173	CcSEcCtD
Fluoxetine—Paraesthesia—Topiramate—obesity	1.39e-05	0.000172	CcSEcCtD
Fluoxetine—Dyspnoea—Topiramate—obesity	1.38e-05	0.000171	CcSEcCtD
Fluoxetine—Somnolence—Topiramate—obesity	1.37e-05	0.00017	CcSEcCtD
Fluoxetine—Dyspepsia—Topiramate—obesity	1.36e-05	0.000169	CcSEcCtD
Fluoxetine—Decreased appetite—Topiramate—obesity	1.34e-05	0.000167	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Topiramate—obesity	1.33e-05	0.000165	CcSEcCtD
Fluoxetine—Fatigue—Topiramate—obesity	1.33e-05	0.000165	CcSEcCtD
Fluoxetine—Pain—Topiramate—obesity	1.32e-05	0.000164	CcSEcCtD
Fluoxetine—Constipation—Topiramate—obesity	1.32e-05	0.000164	CcSEcCtD
Fluoxetine—Feeling abnormal—Topiramate—obesity	1.27e-05	0.000158	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Topiramate—obesity	1.26e-05	0.000157	CcSEcCtD
Fluoxetine—Urticaria—Topiramate—obesity	1.23e-05	0.000152	CcSEcCtD
Fluoxetine—Abdominal pain—Topiramate—obesity	1.22e-05	0.000152	CcSEcCtD
Fluoxetine—Body temperature increased—Topiramate—obesity	1.22e-05	0.000152	CcSEcCtD
Fluoxetine—Hypersensitivity—Topiramate—obesity	1.14e-05	0.000141	CcSEcCtD
Fluoxetine—Asthenia—Topiramate—obesity	1.11e-05	0.000138	CcSEcCtD
Fluoxetine—Pruritus—Topiramate—obesity	1.09e-05	0.000136	CcSEcCtD
Fluoxetine—Diarrhoea—Topiramate—obesity	1.06e-05	0.000131	CcSEcCtD
Fluoxetine—Dizziness—Topiramate—obesity	1.02e-05	0.000127	CcSEcCtD
Fluoxetine—Vomiting—Topiramate—obesity	9.83e-06	0.000122	CcSEcCtD
Fluoxetine—Rash—Topiramate—obesity	9.75e-06	0.000121	CcSEcCtD
Fluoxetine—Dermatitis—Topiramate—obesity	9.74e-06	0.000121	CcSEcCtD
Fluoxetine—Headache—Topiramate—obesity	9.69e-06	0.00012	CcSEcCtD
Fluoxetine—Nausea—Topiramate—obesity	9.18e-06	0.000114	CcSEcCtD
Fluoxetine—CYP2C19—Metabolism—GPX1—obesity	1.08e-06	3e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GNAS—obesity	1.07e-06	3e-05	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—PIK3CA—obesity	1.07e-06	2.99e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IRS1—obesity	1.07e-06	2.99e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PPARG—obesity	1.07e-06	2.97e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—APOB—obesity	1.06e-06	2.97e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GGT1—obesity	1.06e-06	2.96e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GOT1—obesity	1.06e-06	2.96e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TYK2—obesity	1.05e-06	2.94e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—APOB—obesity	1.05e-06	2.94e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—AGT—obesity	1.05e-06	2.93e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—POMC—obesity	1.05e-06	2.93e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GPX1—obesity	1.05e-06	2.93e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CETP—obesity	1.05e-06	2.93e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CD36—obesity	1.05e-06	2.93e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—RHOA—obesity	1.04e-06	2.92e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—INS—obesity	1.04e-06	2.92e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NCOA1—obesity	1.04e-06	2.92e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PPARG—obesity	1.04e-06	2.91e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SDC1—obesity	1.04e-06	2.89e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PIK3R1—obesity	1.03e-06	2.89e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NOS3—obesity	1.03e-06	2.89e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—POMC—obesity	1.03e-06	2.88e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—APOE—obesity	1.03e-06	2.87e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—STK11—obesity	1.03e-06	2.87e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CYP19A1—obesity	1.03e-06	2.87e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—POMC—obesity	1.03e-06	2.87e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—INS—obesity	1.02e-06	2.86e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CD36—obesity	1.02e-06	2.86e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—INS—obesity	1.02e-06	2.85e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CAV1—obesity	1.02e-06	2.85e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—AKR1C3—obesity	1.02e-06	2.85e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—APOA1—obesity	1.02e-06	2.84e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—LPL—obesity	1.01e-06	2.83e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL2—obesity	1.01e-06	2.81e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—LPL—obesity	1.01e-06	2.81e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SCARB1—obesity	1e-06	2.8e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MTHFR—obesity	9.93e-07	2.77e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IGF1—obesity	9.91e-07	2.77e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—AKT2—obesity	9.9e-07	2.76e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GPX1—obesity	9.89e-07	2.76e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—PIK3CA—obesity	9.85e-07	2.75e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GPX1—obesity	9.81e-07	2.74e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.74e-07	2.72e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SREBF1—obesity	9.74e-07	2.72e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PPARA—obesity	9.74e-07	2.72e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PIK3CD—obesity	9.7e-07	2.71e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MTHFR—obesity	9.69e-07	2.71e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CD36—obesity	9.63e-07	2.69e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ALB—obesity	9.58e-07	2.67e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—COMT—obesity	9.57e-07	2.67e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CD36—obesity	9.55e-07	2.67e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PIK3CB—obesity	9.55e-07	2.67e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MTOR—obesity	9.55e-07	2.67e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PIK3CD—obesity	9.51e-07	2.66e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PPARA—obesity	9.5e-07	2.65e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PIK3CD—obesity	9.48e-07	2.65e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GOT2—obesity	9.48e-07	2.65e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PPARGC1A—obesity	9.43e-07	2.63e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GNB3—obesity	9.43e-07	2.63e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—AGT—obesity	9.43e-07	2.63e-05	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—PIK3CA—obesity	9.42e-07	2.63e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SERPINE1—obesity	9.41e-07	2.63e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—HMOX1—obesity	9.39e-07	2.62e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALB—obesity	9.36e-07	2.61e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PIK3CG—obesity	9.29e-07	2.59e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—FASN—obesity	9.28e-07	2.59e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—APOE—obesity	9.24e-07	2.58e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—BCHE—obesity	9.24e-07	2.58e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—AGT—obesity	9.2e-07	2.57e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GNAS—obesity	9.19e-07	2.57e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PIK3R1—obesity	9.16e-07	2.56e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—NOS3—obesity	9.16e-07	2.56e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CAV1—obesity	9.16e-07	2.56e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TYK2—obesity	9.15e-07	2.56e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—APOA1—obesity	9.13e-07	2.55e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MTHFR—obesity	9.13e-07	2.55e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—RHOA—obesity	9.07e-07	2.53e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MTHFR—obesity	9.05e-07	2.53e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—APOE—obesity	9.02e-07	2.52e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—APOB—obesity	9e-07	2.51e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NOS3—obesity	8.98e-07	2.51e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PIK3R1—obesity	8.98e-07	2.51e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PPARG—obesity	8.97e-07	2.5e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PPARA—obesity	8.96e-07	2.5e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PIK3R1—obesity	8.95e-07	2.5e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—NOS3—obesity	8.95e-07	2.5e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CAV1—obesity	8.94e-07	2.5e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—APOA1—obesity	8.92e-07	2.49e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP2E1—obesity	8.91e-07	2.49e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PPARA—obesity	8.88e-07	2.48e-05	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—AKT1—obesity	8.86e-07	2.48e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—POMC—obesity	8.84e-07	2.47e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NQO1—obesity	8.81e-07	2.46e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—INS—obesity	8.79e-07	2.46e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	8.75e-07	2.44e-05	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—AKT1—obesity	8.74e-07	2.44e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL6—obesity	8.72e-07	2.44e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—AGT—obesity	8.67e-07	2.42e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—AGT—obesity	8.6e-07	2.4e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—LPL—obesity	8.59e-07	2.4e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—PIK3CA—obesity	8.55e-07	2.39e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—APOE—obesity	8.5e-07	2.37e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PIK3CB—obesity	8.46e-07	2.36e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GCG—obesity	8.45e-07	2.36e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SLC2A4—obesity	8.45e-07	2.36e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—APOE—obesity	8.43e-07	2.35e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CAV1—obesity	8.42e-07	2.35e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—APOA1—obesity	8.4e-07	2.35e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GPX1—obesity	8.38e-07	2.34e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PTGS2—obesity	8.38e-07	2.34e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CAV1—obesity	8.35e-07	2.33e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PIK3CG—obesity	8.34e-07	2.33e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYCS—obesity	8.34e-07	2.33e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—APOA1—obesity	8.33e-07	2.33e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MMP9—obesity	8.3e-07	2.32e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MTOR—obesity	8.29e-07	2.32e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PIK3CB—obesity	8.29e-07	2.32e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PIK3CB—obesity	8.27e-07	2.31e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PTGS2—obesity	8.19e-07	2.29e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GOT1—obesity	8.18e-07	2.29e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GGT1—obesity	8.18e-07	2.29e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PIK3CD—obesity	8.17e-07	2.28e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CD36—obesity	8.16e-07	2.28e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PIK3CG—obesity	8.14e-07	2.27e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MAPK8—obesity	8.07e-07	2.25e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NCOA1—obesity	8.06e-07	2.25e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PPARG—obesity	8.05e-07	2.25e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—AKT1—obesity	8.05e-07	2.25e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.98e-07	2.23e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—STK11—obesity	7.94e-07	2.22e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP19A1—obesity	7.94e-07	2.22e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—POMC—obesity	7.94e-07	2.22e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—INS—obesity	7.89e-07	2.2e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PPARG—obesity	7.86e-07	2.19e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—POMC—obesity	7.75e-07	2.16e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MTHFR—obesity	7.73e-07	2.16e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PIK3R1—obesity	7.71e-07	2.15e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—NOS3—obesity	7.71e-07	2.15e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—INS—obesity	7.7e-07	2.15e-05	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—AKT1—obesity	7.7e-07	2.15e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PIK3CG—obesity	7.67e-07	2.14e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PIK3CG—obesity	7.6e-07	2.12e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PPARA—obesity	7.59e-07	2.12e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL6—obesity	7.58e-07	2.12e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PPARG—obesity	7.4e-07	2.07e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—COMT—obesity	7.38e-07	2.06e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—STAT3—obesity	7.38e-07	2.06e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—AGT—obesity	7.35e-07	2.05e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PPARG—obesity	7.34e-07	2.05e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PIK3CD—obesity	7.33e-07	2.05e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—POMC—obesity	7.3e-07	2.04e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GNB3—obesity	7.28e-07	2.03e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PPARGC1A—obesity	7.28e-07	2.03e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—INS—obesity	7.26e-07	2.03e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—HMOX1—obesity	7.25e-07	2.02e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—POMC—obesity	7.24e-07	2.02e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALB—obesity	7.24e-07	2.02e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MMP9—obesity	7.21e-07	2.01e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—APOE—obesity	7.2e-07	2.01e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—INS—obesity	7.2e-07	2.01e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PIK3CD—obesity	7.16e-07	2e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CAV1—obesity	7.13e-07	1.99e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PIK3CB—obesity	7.12e-07	1.99e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—APOA1—obesity	7.12e-07	1.99e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GNAS—obesity	7.09e-07	1.98e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALB—obesity	7.06e-07	1.97e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PTGS2—obesity	7.05e-07	1.97e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MAPK8—obesity	7.01e-07	1.96e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—AKT1—obesity	6.99e-07	1.95e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—APOB—obesity	6.94e-07	1.94e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PIK3R1—obesity	6.92e-07	1.93e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—NOS3—obesity	6.92e-07	1.93e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MYC—obesity	6.86e-07	1.91e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TGFB1—obesity	6.84e-07	1.91e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	6.82e-07	1.9e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PIK3R1—obesity	6.76e-07	1.89e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—NOS3—obesity	6.76e-07	1.89e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PIK3CD—obesity	6.74e-07	1.88e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PIK3CD—obesity	6.68e-07	1.87e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALB—obesity	6.66e-07	1.86e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—LPL—obesity	6.63e-07	1.85e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALB—obesity	6.6e-07	1.84e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PIK3CG—obesity	6.5e-07	1.81e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GPX1—obesity	6.47e-07	1.81e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—STAT3—obesity	6.41e-07	1.79e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PIK3CB—obesity	6.39e-07	1.78e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PIK3R1—obesity	6.37e-07	1.78e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—NOS3—obesity	6.37e-07	1.78e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PTGS2—obesity	6.33e-07	1.77e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PIK3R1—obesity	6.31e-07	1.76e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—NOS3—obesity	6.31e-07	1.76e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CD36—obesity	6.3e-07	1.76e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PPARG—obesity	6.27e-07	1.75e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PIK3CB—obesity	6.24e-07	1.74e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—POMC—obesity	6.19e-07	1.73e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PTGS2—obesity	6.18e-07	1.73e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—INS—obesity	6.15e-07	1.72e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MTHFR—obesity	5.97e-07	1.67e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MYC—obesity	5.95e-07	1.66e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TGFB1—obesity	5.94e-07	1.66e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PIK3CB—obesity	5.88e-07	1.64e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PPARA—obesity	5.86e-07	1.64e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PIK3CB—obesity	5.83e-07	1.63e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PTGS2—obesity	5.82e-07	1.63e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PIK3CA—obesity	5.82e-07	1.63e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PTGS2—obesity	5.77e-07	1.61e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PIK3CD—obesity	5.71e-07	1.6e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—AGT—obesity	5.67e-07	1.58e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALB—obesity	5.64e-07	1.57e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—APOE—obesity	5.56e-07	1.55e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CAV1—obesity	5.51e-07	1.54e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—APOA1—obesity	5.49e-07	1.53e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PIK3R1—obesity	5.39e-07	1.51e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NOS3—obesity	5.39e-07	1.51e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PIK3CA—obesity	5.15e-07	1.44e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL6—obesity	5.15e-07	1.44e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PIK3CA—obesity	5.05e-07	1.41e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PIK3CA—obesity	5.04e-07	1.41e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PIK3CG—obesity	5.01e-07	1.4e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PIK3CB—obesity	4.98e-07	1.39e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PTGS2—obesity	4.93e-07	1.38e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PPARG—obesity	4.84e-07	1.35e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—POMC—obesity	4.77e-07	1.33e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—AKT1—obesity	4.75e-07	1.33e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—INS—obesity	4.75e-07	1.33e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL6—obesity	4.47e-07	1.25e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PIK3CD—obesity	4.41e-07	1.23e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALB—obesity	4.35e-07	1.22e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PIK3CA—obesity	4.34e-07	1.21e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—AKT1—obesity	4.21e-07	1.18e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NOS3—obesity	4.16e-07	1.16e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PIK3R1—obesity	4.16e-07	1.16e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—AKT1—obesity	4.13e-07	1.15e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—AKT1—obesity	4.12e-07	1.15e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PIK3CA—obesity	3.9e-07	1.09e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PIK3CB—obesity	3.84e-07	1.07e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PTGS2—obesity	3.81e-07	1.06e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PIK3CA—obesity	3.8e-07	1.06e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PIK3CA—obesity	3.58e-07	1e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PIK3CA—obesity	3.55e-07	9.92e-06	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—AKT1—obesity	3.54e-07	9.9e-06	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—AKT1—obesity	3.18e-07	8.89e-06	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—AKT1—obesity	3.11e-07	8.67e-06	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PIK3CA—obesity	3.04e-07	8.48e-06	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—AKT1—obesity	2.93e-07	8.17e-06	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—AKT1—obesity	2.9e-07	8.1e-06	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—AKT1—obesity	2.48e-07	6.92e-06	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PIK3CA—obesity	2.34e-07	6.54e-06	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—AKT1—obesity	1.91e-07	5.34e-06	CbGpPWpGaD
